Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $46.9800 (1.05%) ($46.9800 - $46.9800) on Sun. Feb. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 63 | Latest Price | $46.9800(1.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.2% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -1.555% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $47.07 | 5 Day Moving Average | $47.15(-0.36%) | 10 Day Moving Average | $48.37(-2.87%) | 20 Day Moving Average | $47.07(-0.19%) | To recent high | -10.7% | To recent low | 26.6% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |